Tester David J, Arya Puneeta, Will Melissa, Haglund Carla M, Farley Amanda L, Makielski Jonathan C, Ackerman Michael J
Department of Molecular Pharmacology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Heart Rhythm. 2006 Jul;3(7):800-5. doi: 10.1016/j.hrthm.2006.03.025. Epub 2006 Mar 28.
Mutations in the RyR2-encoded cardiac ryanodine receptor/calcium release channel and in CASQ2-encoded calsequestrin cause catecholaminergic polymorphic ventricular tachycardia (CPVT1 and CPVT2, respectively).
The purpose of this study was to evaluate the extent of genotypic and phenotypic heterogeneity among referrals for CPVT genetic testing.
Using denaturing high-performance liquid chromatography and DNA sequencing, mutational analysis of 23 RyR2 exons previously implicated in CPVT1, comprehensive analysis of all translated exons in CASQ2 (CPVT2), KCNQ1 (LQT1), KCNH2 (LQT2), SCN5A (LQT3), KCNE1 (LQT5), KCNE2 (LQT6), and KCNJ2 (Andersen-Tawil syndrome [ATS1], also annotated LQT7), and analysis of 10 ANK2 exons implicated in LQT4 were performed on genomic DNA from 11 unrelated patients (8 females) referred to Mayo Clinic's Sudden Death Genomics Laboratory explicitly for CPVT genetic testing.
Overall, putative disease causing mutations were identified in 8 patients (72%). Only 4 patients (3 males) hosted CPVT1-associated RyR2 mutations: P164S, V186M, S3938R, and T4196A. Interestingly, 4 females instead possessed either ATS1- or LQT5-associated mutations. Mutations were absent in >400 reference alleles.
Putative CPVT1-causing mutations in RyR2 were seen in <40% of unrelated patients referred with a diagnosis of CPVT and preferentially in males. Phenotypic mimicry is evident with the identification of ATS1- and LQT5-associated mutations in females displaying a normal QT interval and exercise-induced bidirectional VT, suggesting that observed exercise-induced polymorphic VT in patients may reflect disorders other than CPVT. Clinical consideration for either Andersen-Tawil syndrome or long QT syndrome and appropriate genetic testing may be warranted for individuals with RyR2 mutation-negative CPVT, particularly females.
由兰尼碱受体2(RyR2)编码的心脏兰尼碱受体/钙释放通道以及由肌集钙蛋白2(CASQ2)编码的肌集钙蛋白发生突变,分别导致儿茶酚胺能多形性室性心动过速(CPVT1和CPVT2)。
本研究旨在评估CPVT基因检测转诊病例中基因型和表型异质性的程度。
采用变性高效液相色谱法和DNA测序技术,对先前与CPVT1相关的23个RyR2外显子进行突变分析,对CASQ2(CPVT2)、KCNQ1(LQT1)、KCNH2(LQT2)、SCN5A(LQT3)KCNE1(LQT5)、KCNE2(LQT6)和KCNJ2(安德森-陶威尔综合征[ATS1],也标注为LQT7)的所有翻译外显子进行全面分析,并对10个与LQT4相关的锚蛋白2(ANK2)外显子进行分析,这些分析均在来自11名无血缘关系患者(8名女性)的基因组DNA上进行,这些患者被明确转诊至梅奥诊所猝死基因组学实验室进行CPVT基因检测。
总体而言,在8名患者(72%)中鉴定出可能致病的突变。只有4名患者(3名男性)携带与CPVT1相关的RyR2突变:P164S、V186M、S3938R和T4196A。有趣的是,4名女性反而携带与ATS1或LQT5相关的突变。在400多个参考等位基因中未发现突变。
在诊断为CPVT的无血缘关系患者中,不到40%的患者检测到可能导致CPVT1的RyR2突变,且男性更易出现。在QT间期正常且运动诱发双向室性心动过速的女性中鉴定出与ATS1和LQT5相关的突变,这表明表型模拟很明显,提示患者中观察到的运动诱发多形性室性心动过速可能反映了CPVT以外的疾病。对于RyR2突变阴性的CPVT患者,尤其是女性,可能有必要临床考虑安德森-陶威尔综合征或长QT综合征并进行适当的基因检测。